Portal de Periódicos da CAPES

A young woman with chronic hepatitis

1993; Lippincott Williams & Wilkins; Volume: 17; Issue: 4 Linguagem: Inglês

10.1002/hep.1840170430

1527-3350

Anna S. Lok, Michael A. Gerber,

Pancreatitis Pathology and Treatment

HepatologyVolume 17, Issue 4 p. 739-745 Clinicopathology ConferencesFree Access A young woman with chronic hepatitis Anna S. F. Lok M.D., Corresponding Author Anna S. F. Lok M.D. Department of Medicine, Section of Gastroenterology and Department of Pathology and Laboratory Medicine, Tulane University Medical Center, New Orleans, Louisiana 70112Section of Gastroenterology, Tulane University Medical Center, 1430 Tulane Avenue, New Orleans, LA 70112===Search for more papers by this authorMichael A. Gerber, Michael A. Gerber Department of Medicine, Section of Gastroenterology and Department of Pathology and Laboratory Medicine, Tulane University Medical Center, New Orleans, Louisiana 70112Search for more papers by this author Anna S. F. Lok M.D., Corresponding Author Anna S. F. Lok M.D. Department of Medicine, Section of Gastroenterology and Department of Pathology and Laboratory Medicine, Tulane University Medical Center, New Orleans, Louisiana 70112Section of Gastroenterology, Tulane University Medical Center, 1430 Tulane Avenue, New Orleans, LA 70112===Search for more papers by this authorMichael A. Gerber, Michael A. Gerber Department of Medicine, Section of Gastroenterology and Department of Pathology and Laboratory Medicine, Tulane University Medical Center, New Orleans, Louisiana 70112Search for more papers by this author First published: April 1993 https://doi.org/10.1002/hep.1840170430Citations: 2AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 McFarlane IG, Smith HM, Johnson PJ, Bray GP, Vergani D, Williams R. Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet 1990; 335: 754– 757. 2 Lenzi M, Johnson PJ, McFarlane IG, Ballardini G, Smith HM, McFarlane BM, Bridger C, et al. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 1991; 338: 277– 280. 3 Czaja AJ, Taswell HF, Rakela J, Rabe D. Duration and specificity of antibodies to hepatitis C virus in chronic active hepatitis. Gastroenterology 1992; 102: 1675– 1679. 4 Nishiguchi S, Kuroki T, Ueda T, Fukuda K, Takeda T, Nakajima S, Shiomi S, et al. Detection of hepatitis C virus antibody in the absence of viral RNA in patients with autoimmune hepatitis. Ann Intern Med 1992; 116: 21– 25. 5 Todros L, Touscoz G, D'Urso N, Durazzo M, Albano E, Poli G, Baldi M, et al. Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM) J Hepatol 1991; 13: 128– 131. 6 Garson JA, Lenzi M, Ring C, Cassani F, Ballardini G, Briggs M, Tedder RS, et al. Hepatitis C viraemia in adults with type 2 autoimmune hepatitis. J Med Virol 1991; 34: 223– 226. 7 Lunel F, Abuaf N, Frangeul L, Grippon P, Perrin M, Coz YL, Valla D, et al. Liver/kidney microsome antibody type 1 and hepatitis C virus infection. HEPATOLOGY 1992; 16: 630– 636. 8 Maddrey WC. Subdivisions of idiopathic autoimmune chronic active hepatitis. HEPATOLOGY 1987; 7: 1372– 1375. 9 Meyer zum Büschenfelde KH, Lohse AW, Manns M, Poralla T. Autoimmunity and liver disease. HEPATOLOGY 1990; 12: 354– 363. 10 Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, Poupon R, et al. Chronic active hepatitis associated with anti-liver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. HEPATOLOGY 1987; 7: 1333– 1339. 11 Manns MP, Johnson EF, Griffin KJ, Tan EM, Sullivan KF. Major antigen of liver kidney microsomal antibodies in idiopathic autoimmune hepatitis is cytochrome P450 db1. J Clin Invest 1989; 83: 1066– 1072. 12 Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest 1991; 88: 1370– 1378. 13 Saracco F, Rosina F, Cerezia MRT, Lattore V, Chiandussi L, Gallo V, Petrino R, et al. A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitis J Hepatol 1990; 11 (suppl): S43– S49. 14 Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 1992; 103: 1290– 1295. 15 Mishiro S, Hoshi Y, Takeda K, Yoshikawa A, Gotanda T, Takahashi K, Akahane Y, et al. Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process. Lancet 1990; 336: 1400– 1403. 16 Michel G, Ritter A, Gerken G, Meyer zum Büschenfelde KH, Decker R, Manns MP. Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet 1992; 339: 267– 269. 17 Homberg JC, Andre C, Abuaf N. A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid–induced hepatitis. Clin Exp Immunol 1984; 55: 561– 570. 18 Crivelli O, Lavarini C, Chiaberge E, Amoroso A, Farci P, Negro F, Rizzetto M. Microsomal autoantibodies in chronic infection with the HBsAg associated delta agent. Clin Exp Immunol 1983; 54: 232– 238. 19 Vento S, Garofano T, DiPerri G, Dolci L, Concia E, Bassetti D. Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals. Lancet 1991; 337: 1183– 1187. 20 Triger DR, Kurtz JB, Maccallum FO, Wright R. Raised antibody titres to measles and rubella viruses in chronic active hepatitis. Lancet 1972; 1: 665– 667. 21 Robertson DAF, Zhang SK, Guy EC, Wright R. Persistent measles virus genome in autoimmune chronic active hepatitis. Lancet 1987; 2: 9– 11. 22 Alter HJ, Purcel RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494– 1500. 23 Dittman S, Roggendorf M, Durkop J, Wiese M, Lorbeer B, Deinhardt F. Long-term persistence of hepatitis C virus antibodies in a single source outbreak. J Hepatol 1991; 13: 323– 327. 24 Gibson T, Myers AR. Subclinical liver disease in systemic lupus erythematosus. J Rheumatol 1981; 8: 752– 759. 25 Runyon EA, LaBrecque DR, Anuras N. The spectrum of liver disease in systemic lupus erythematosus. Am J Med 1980; 69: 187– 194. 26 Miller MH, Urowitz MB, Gladman DD, Blendis LM. The liver in systemic lupus erythematosus. Q J Med 1984; 53: 401– 409. 27 deHoratius RJ, Pillarisetty R, Messner RP, Talal N. Anti-nucleic acid antibodies in systemic lupus erythematosus patients and their families: incidence and correlation with lymphocytotoxic antibodies. J Clin Invest 1975; 56: 1149– 1154. 28 Arnett FC, Shulman LE. Studies in familial systemic lupus erythematosus. Medicine 1976; 55: 313– 320. 29 Almasio P, Provenzano G, Samemi M, Cascio G, Craxi A, Pagliaro L. Hepatitis C virus and Sjögren's syndrome. Lancet 1992; 339: 989– 990. 30 Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D, Mal F, et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339: 321– 323. 31 Gerber MA. Chronic hepatitis C: the beginning of the end of a time-honored nomenclature? HEPATOLOGY 1992; 15: 733– 734. 32 Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. HEPATOLOGY 1992; 15: 572– 577. 33 Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. HEPATOLOGY 1992; 15: 567– 571. 34 Gerber MA, Krawczynski K, Alter MJ, Sampliner RE, Margolis HS. Sentinel counties chronic non-A, non-B hepatitis study team: histopathology of community acquired chronic hepatitis C. Mod Pathol 1992; 5: 483– 486. 35 Matsumoto T, Yoshimine T, Shimouchi K, Shiotu H, Kuwabara N, Fukuda Y, Hoshi T. The liver in systemic lupus erythematosus: pathologic analysis of 52 cases and review of Japanese autopsy registry data. Hum Pathol 1992; 23: 115– 118. 36 Akyol G, Dash S, Shieh CYS, Malter JS, Gerber MA. Detection of hepatitis C virus RNA sequences by polymerase chain reaction in fixed liver tissue. Mod Pathol 1992; 5: 501– 504. 37 Hiramatsu N, Hayashi N, Haruna Y, Kasahara A, Fusamoto H, Mori C, Fuke I, et al. Immunohistochemical detection of hepatitis C virus–infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome. HEPATOLOGY 1992; 16: 306– 311. 38 Camma C, Craxi A, Tine F, Alamsio P, DiMarco V, LoIacono O, Bruno R, et al. Predictors of response to alpha-interferon (IFN) in chronic hepatitis C: a multivariate analysis on 361 treated patients [Abstract]. HEPATOLOGY 1992; 16: 131A. 39 Causse X, Godinot H, Chevallier M, Chossegros P, Zoulim F, Ouzan D, Heyraud JP, et al. Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology 1191; 101: 497– 502. 40 Mayet WJ, Hess G, Gerken G, Rossol S, Voth R, Manns M, Meyer zum Büschenfelde KH. Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. HEPATOLOGY 1989; 10: 24– 28. 41 Fattovich G, Betterle C, Brollo L, Pedini B, Giustina G, Realdi G, Alberti A, et al. Autoantibodies during alpha-interferon therapy for chronic hepatitis B. J Med Virol 1991; 34: 132– 135. 42 Shindo M, DiBisceglie AM, Hoofnagle JH. Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C. Gastroenterology 1992; 102: 1406– 1408. 43 Silva MO, Reddy KR, Jeffers LJ, Hill M, Schiff ER. Interferoninduced chronic active hepatitis? Gastroenterology 1991; 101: 840– 842. 44 Papo T, Marcellin P, Bernuau J, Durand F, Poynard T, Benhamou JP. Autoimmune chronic hepatitis exacerbated by alphainterferon. Ann Intern Med 1992; 116: 51– 53. 45 Magrin S, Craxi A, Fabiano C, Fiorentino G, Almasio P, Palazzo U, Pinzello G, et al. Hepatitis C virus replication in "autoimmune" chronic hepatitis. J Hepatol 1991; 13: 364– 367. 46 Seeff LB and the National Heart, Lung and Blood Institute Hepatitis Study Group. Mortality of non-A, non-B transfusion-associated hepatitis (NANB TAH) in the U.S. 18 years after infection [Abstract]. HEPATOLOGY 1991; 14: 90A. 47 Pereira AJG, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991; 325: 454– 460. 48 Wright TL, Hollander H, Kim M, Wilber J, Chan C, Polito A, Urdea M, et al. Hepatitis C viremia in human immunodeficiency virus (HIV) infected patients with and without AIDS [Abstract]. HEPATOLOGY 1992; 16: 70A. 49 Schoeman MN, Liddle C, Bilous M, Grierson J, Craig PI, Batey RG, Farrell GC. Chronic non-A, non-B hepatitis: lack of correlation between biochemical and morphological activity, and effects of immunosuppressive therapy on disease progression. Aust NZ J Med 1990; 20: 56– 62. Citing Literature Volume17, Issue4April 1993Pages 739-745 ReferencesRelatedInformation